{"id":89848,"date":"2026-01-24T12:46:37","date_gmt":"2026-01-24T12:46:37","guid":{"rendered":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/"},"modified":"2026-01-24T12:46:37","modified_gmt":"2026-01-24T12:46:37","slug":"lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water","status":"publish","type":"post","link":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/","title":{"rendered":"Lupin Earns Top CDP A Rating for Efforts in Combating Climate Change and Conserving Water"},"content":{"rendered":"<p>Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest &#8216;A&#8217; leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin&#8217;s commitment to sustainability and transparency, placing the company among the world&#8217;s leading organizations that prioritize environmental stewardship.<\/p>\n<p>Lupin&#8217;s double &#8216;A&#8217; rating in Climate and Water demonstrates its proactive approach to mitigating climate risks, reducing carbon emissions, and ensuring responsible water management throughout its operations. This achievement represents a significant improvement from the company&#8217;s previous ratings, with a substantial enhancement from &#8216;A-&#8216; in 2024 and &#8216;B&#8217; in 2023 for climate, and &#8216;C&#8217; for water. This progress reflects Lupin&#8217;s dedication to continuous improvement and its efforts to establish new sustainability standards.<\/p>\n<p>The company&#8217;s Executive Director, Ramesh Swaminathan, attributed this achievement to Lupin&#8217;s innovative approaches, collaborative efforts, and transparency. He emphasized that the CDP&#8217;s framework has helped shape and accelerate the company&#8217;s climate initiatives, driving ongoing progress. Lupin&#8217;s commitment to sustainability is also reflected in its S&#038;P Global ESG score of 91 in 2025, which is a best-in-class global achievement. This score positions Lupin among a select group of companies worldwide that have surpassed the 90-point threshold, demonstrating its exceptional performance in environmental, social, and governance (ESG) aspects.<\/p>\n<p>Lupin&#8217;s achievement is a significant milestone in the pharmaceutical industry, highlighting the company&#8217;s dedication to reducing its environmental impact while generating lasting value for its communities and the planet. By prioritizing sustainability and transparency, Lupin is setting a high standard for the industry and demonstrating its commitment to creating a better future for all stakeholders. Overall, Lupin&#8217;s double &#8216;A&#8217; rating from CDP and its exceptional ESG score are a testament to the company&#8217;s leadership in sustainability and its efforts to make a positive impact on the environment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest &#8216;A&#8217; leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin&#8217;s commitment to sustainability and transparency, placing the company among the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[20,2],"tags":[],"class_list":["post-89848","post","type-post","status-publish","format-standard","hentry","category-lupin","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89870,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/lupin-achieves-top-esg-rating-from-cdp-for-its-efforts-in-addressing-climate-change-and-water-security\/","url_meta":{"origin":89848,"position":0},"title":"Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest \"A\" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition solidifies Lupin's position among the world's most sustainable and transparent companies. The double \"A\" rating\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89855,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/25\/lupin-achieves-prestigious-cdp-double-a-rating-for-excellence-in-climate-change-mitigation-and-water-stewardship\/","url_meta":{"origin":89848,"position":1},"title":"Lupin Achieves Prestigious CDP Double &#8216;A&#8217; Rating for Excellence in Climate Change Mitigation and Water Stewardship","author":"Team Small News","date":"January 25, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double 'A' rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin's efforts to reduce its environmental impact and\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89844,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/lupin-achieves-top-esg-score-from-cdp-for-efforts-in-combating-climate-change-and-ensuring-water-security-reported-by-chennai-patrika\/","url_meta":{"origin":89848,"position":2},"title":"Lupin Achieves Top ESG Score from CDP for Efforts in Combating Climate Change and Ensuring Water Security &#8211; Reported by Chennai Patrika.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin's position as a global leader in championing sustainability\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89877,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/29\/sp-global-upgrades-biocon-biologics-credit-rating-to-bb-with-a-stable-outlook-reports-indiamedtoday\/","url_meta":{"origin":89848,"position":3},"title":"S&amp;P Global Upgrades Biocon Biologics&#8217; Credit Rating to &#8216;BB+&#8217; with a Stable Outlook, Reports IndiaMedToday","author":"Team Small News","date":"January 29, 2026","format":false,"excerpt":"S&P Global Ratings has upgraded the long-term issuer credit rating of Biocon Biologics, a subsidiary of Biocon Limited, to 'BB+' from 'BB'. The rating agency has also maintained a stable outlook for the company. This upgrade is a testament to Biocon Biologics' strong business profile, driven by its robust product\u2026","rel":"","context":"In &quot;Biocon&quot;","block_context":{"text":"Biocon","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/biocon\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89907,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/02\/06\/piramal-critical-care-collaborates-with-blue-zone-to-launch-innovative-waste-anaesthetic-gas-recycling-initiative\/","url_meta":{"origin":89848,"position":4},"title":"Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.","author":"Team Small News","date":"February 6, 2026","format":false,"excerpt":"Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes\u2026","rel":"","context":"In &quot;Pharma&quot;","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89849,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/delhi-high-court-dismisses-alkems-bid-to-trademark-a-to-z\/","url_meta":{"origin":89848,"position":5},"title":"Delhi High Court Dismisses Alkem&#8217;s Bid to Trademark &#8216;A TO Z&#8217;","author":"Team Small News","date":"January 24, 2026","format":false,"excerpt":"The Delhi High Court has rejected a trademark claim by Alkem Laboratories, a pharmaceutical company, over the use of the term \"A TO Z\" for its products. The court ruled that alphabets are public property and cannot be monopolized by a single entity. Alkem Laboratories had filed a lawsuit against\u2026","rel":"","context":"In &quot;Alkem&quot;","block_context":{"text":"Alkem","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/alkem\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89848"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89848\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}